Mycobacterium fortuitum peritoneal dialysis-related peritonitis in a child: A case report and review of the literature.

Kathryn Haubrich Cherry Mammen Inna Sekirov Hana Mijovic

Published in: Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada (2022)

Therapeutic options were limited by adverse medication effects and risk of drug-drug interactions in a patient with complex mental health comorbidities. Clofazimine presented an acceptable oral treatment option for long-term therapy in combination with ciprofloxacin and was well tolerated by this patient. Prompt PD catheter removal followed by 6 months of dual antimicrobial therapy resulted in a full recovery and successful re-transplantation with no infection relapse.

Keyphrases

peritoneal dialysis
mental health
end stage renal disease
case report
adverse drug
healthcare
mycobacterium tuberculosis
chronic kidney disease
pseudomonas aeruginosa
mental illness
cell therapy
stem cells
emergency department
mesenchymal stem cells
cystic fibrosis
bone marrow
replacement therapy